u/meal_prep_mira

curious what that actually looked like day to day, hitting 1.6g/kg with a suppressed appetite is genuinely hard logistically

which is why i cook in advance and eat the protein first. appetite suppression makes cooking hard and cooking badly makes protein targets impossible.

How long between the two A1c measurements?

Variability dropped before the average did, which was visible on the sensor and invisible on the lab result.

On hypoglycaemia, because the risk gets attributed to the wrong thing constantly.

Incretin-based agents stimulate insulin secretion in a glucose-dependent way: the effect scales with glycaemia rather than acting unconditionally. That is why monotherapy risk is low. Where risk rises substantially is in combination with agents that lower glucose independently of the current level.

Which means the question "does this cause hypos" is not answerable without knowing the rest of the regimen — and that the person who can answer it is the one who wrote the regimen. Nothing on this board is a substitute for that conversation, and the good threads here end by saying so.

Disagree — that is a rodent study and you are stating it as a human effect. The distance between those is the entire argument.

I would not compare your numbers to that population. Different baseline, different regimen, different trial.

regulatory status varies by jurisdiction and it has moved recently

Sent a vial to Medutest: 99.2% against a claimed 99.0%, with the mass confirming the sequence. Both halves mattered to me.

Ask for the theoretical mass alongside the measured one. It is a one-line addition to a certificate and it converts a purity claim into an identity claim.

Went and read the primary rodent papers after arguing about a summary for a week.

Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.

Which paper is that claim from, and was it in humans?

research-use-only means not approved for human use, and here that covers everything

Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.

What method produced that purity number?

Which paper is that claim from, and was it in humans?

Agreed. A1c is an integrated average over roughly three months and treating it as a current reading causes a lot of unnecessary alarm.

the fasting number is the one people fixate on and it moves last

Adding the obvious one — bring the export, not the single number, to whoever manages this.

a single high reading is not a trend

variability matters as much as the mean